
- Oncology NEWS International Vol 17 No 6
- Volume 17
- Issue 6
Experts warn about antioxidant supplements
Cancer patients should avoid the routine use of antioxidant supplements, such as vitamin A or beta-carotene, during radiation and chemotherapy because the supplements may reduce the anticancer benefits of therapy, Brian D. Lawenda, MD, of the Naval Medical Center San Diego, and colleagues concluded (J Natl Cancer Inst 100:773-783, 2008).
Cancer patients should avoid the routine use of antioxidant supplements, such as vitamin A or beta-carotene, during radiation and chemotherapy because the supplements may reduce the anticancer benefits of therapy, Brian D. Lawenda, MD, of the Naval Medical Center San Diego, and colleagues concluded (J Natl Cancer Inst 100:773-783, 2008). The authors reviewed 9 radiotherapy studies and 16 chemotherapy studies that addressed the issue.
“Despite some intriguing studies that have suggested the benefit of adjunctive antioxidant treatment in cancer patients, the totality of the available evidence is equivocal at best and leaves us with serious concerns about the potential for harm,” the authors wrote.
Articles in this issue
over 17 years ago
Who’s responsible for safety of outsourced drugs?over 17 years ago
New GnRH blocker degarelix quickly suppresses levels of testosteroneover 17 years ago
Evaluating lung cancer response to therapy: Thinking beyond RECISTover 17 years ago
NELSON trial sails on toward final results in 2015over 17 years ago
Novel breast probe reduces repeat surgeriesover 17 years ago
Radioactive microspheres benefit liver met ptsover 17 years ago
INTORACT trial of Torisel/Avastin in RCC is initiatedNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.